Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1 2

Status

Recruiting 3Not yet recruiting 1Completed 1

Sponsor Class

OTHER 5

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Genitourinary 5Breast 2Gynecologic 1Gastrointestinal 1

Conditions

Breast Neoplasms 20Neoplasms 17Lung Neoplasms 11Carcinoma, Non-Small-Cell Lung 9Uterine Cervical Neoplasms 5Prostatic Neoplasms 5Pancreatic Neoplasms 5Colorectal Neoplasms 5Brain Neoplasms 5Ovarian Neoplasms 4Myelodysplastic Syndromes 4Melanoma 4Leukemia, Myeloid, Acute 4Carcinoma, Hepatocellular 4Triple Negative Breast Neoplasms 3Skin Neoplasms 3Neoplasm Metastasis 3Kidney Neoplasms 3Carcinoma, Renal Cell 3Uveal Melanoma 2Recurrence 2Myeloproliferative Disorders 2Lymphoma, Non-Hodgkin 2Lymphoma, B-Cell 2Lymphoma 2Lung Diseases 2Hodgkin Disease 2Head and Neck Neoplasms 2Glioma 2Glioblastoma 2

Interventions

Magnetic Resonance Spectroscopy 56enzalutamide 44Specimen Handling 37apalutamide 35Androgen Antagonists 35Abiraterone Acetate 29Prednisone 27Radiosurgery 26darolutamide 25Docetaxel 23Pluvicto 22abiraterone 21Radiotherapy 21Leuprolide 20Biopsy 16relugolix 14acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 14gallium 68 PSMA-11 12Triptorelin Pamoate 12Surveys and Questionnaires 12Radiation 12Gonadotropin-Releasing Hormone 12X-Rays 112-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 10cabazitaxel 9bicalutamide 9Standard of Care 9Nivolumab 9Goserelin 9Carboplatin 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Prostatic Neoplasms × Blood Specimen Collection × 90 days × Clear all
NCT07555600 2026-04-29

E-FACTOR

Centre Leon Berard

Phase NA Not yet recruiting
300 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

NCT07054346 2026-04-01

LUTACT

University of California, San Francisco

Phase 1 Recruiting
45 enrolled
Genitourinary

Disease, Prostatic Neoplasms

NCT04167969 2026-03-27

The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer

Memorial Sloan Kettering Cancer Center

Phase 1 Recruiting
16 enrolled
Genitourinary

Prostatic Neoplasms

NCT06435546 2026-03-27

AdOTAC

Institut de Cancérologie de Lorraine

Phase NA Completed
200 enrolled
BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT05435495 2026-03-18

Mechanisms of Resistance to PSMA Radioligand Therapy

University of California, San Francisco

Recruiting
125 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡